Home
Pontifax Management 4 G.P. reported a 6.3% stake in LB Pharmaceuticals LBRX · 1,411,681 sh
Trade details
- Type
- 5% stake report
- Report
- 13D
- Stake
- 6.3%
- Last report
- First report
- Shares held
- 1,411,681 sh
- Class
- Common Stock, $0.0001 par value per share
- Event date
- 25/09/12
- Filed
- 25/09/25
First 5%+ report · 6.3% stake
LB Pharmaceuticals trades, last 26 weeks
What else happened in LB Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/08/13~25/10/12Pontifax Management 4 G.P.'s other 5% stake reports
- Pontifax Management 4 G.P.
5% stakeAgomAb Therapeutics
5% stakeAgomAb Therapeutics
AGMB
6.8% stake
3,305,846 sh
6.8% stake
Filed 04/16
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
0% stake
0 sh
0% stake
Filed 25/10/16
- Pontifax Management 4 G.P.
5% stakeClimb Bio
5% stakeClimb Bio
CLYM
7.7% stake
5,206,380 sh
7.7% stake
Filed 25/09/18
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
11.8% stake
4,787,331 sh
11.8% stake
Filed 25/04/18
